[O5] Oral Presentation
neuroinfection/neuroimmunological disease 1

[O-023] Efficacy of interferon-β for myelin oligodendrocyte glycoprotein antibody-positive disorder.

^○Kimihiko Kaneko¹, Douglas Sato^1,2, Ryo Ogawa¹, Tetsuya Akaishi¹, Yoshiki Takai¹, Syuhei Nishiyama¹, Toshiyuki Takahashi^1,3, Tatsuro Misu¹, Hiroshi Kuroda¹, Ichiro Nakashima^1,4,5, Kazuo Fujihara^1,4,5, Masashi Aoki¹ (1.Department of neurology, Tohoku University, Sendai, Japan, 2.Brain Institute and Hospital Sao Lucas Pontifical Catholic University of Rio Grande do Sul, Port Alegre, Brazil, 3.Department of neurology, NHO Yonezawa hospital, Yonezawa, Japan, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan, 5.Multiple Sclerosis and Neuromyelitis Optica Center, TOHOKU Research Institute for Neuroscience, Koriyama, Japan)